| Professor Moussa Youdim |
| Written by Henk van Esch |
| Tuesday, 02 September 2008 10:18 |
|
He is incumbent of the Technion's Finkelstein Chair in Life Sciences and Pharmacology at the Technion, and the director of the Eve Topf and U.S. National Parkinson Foundation Center of Excellence for Neurodegenerative Diseases Research and Teaching. He is known internationally for his research and drug development activities in depressive illness and Parkinson's and Alzheimer's diseases. Following two decades of intense research, Profs. Youdim and John Finberg in collaboration with Teva Pharmaceuticals developed the Azilect drug which promises real hope for millions of patients suffering from Parkinson's Disease and is now being marketed worldwide. Professor Youdim in London Professor Youdim gave the prestigious Ron Arad Lecture in London on Monday evening.Professor Youdim was joined by the new Israel Ambassador to London, Ron Proser, and the family of kidnapped Technion student, Ehud Goldwasser.300 guests filled the Royal College of Physicians to hear from Professor Youdim, Director of the Eve Topf Neurodegenerative Disease Center at the Technion, who discussed the science behind Parkinson's and Alzheimer's diseases, his discovery of anti-Parkinson drug rasagiline and the novel new drugs currently under development which will transform the lives of sufferers in the future. Lois Peltz, Co-Chair of the British Technion Society, said: "Professor Youdim's research once again places the Technion at the forefront of scientific attainment.
Published on: 11/26/2007 by www.britishtechnionsociety.org
|
| Last Updated on Friday, 24 October 2008 09:43 |

